Background {#Sec1}
==========

Medicinal plants have long been recognised as important sources of therapeutically active compounds. Evidence-based research supports the medical and pharmacological benefits of plant-derived compounds, with increasing interest in the identification and characterization of bioactive compounds from natural sources \[[@CR1]\].

One of the earliest recorded approaches for treating inflammation and pain was the application of extracts from willow leaves by Celsius in 30 AD \[[@CR2]\]. This observation led to the discovery of acetyl salicylic acid, the active component of aspirin, a major anti-inflammatory drug widely used in clinical practice, along with many other non-steroidal anti-inflammatory drugs (NSAIDs) in current use \[[@CR3]\].

Non-steroidal anti-inflammatory drugs are commonly prescribed for treatment of pain and inflammatory conditions such as rheumatoid arthritis, osteoporosis and Alzheimer's disease. However, because many NSAIDs are associated with side effects such as gastrointestinal bleeding and suppressed function of the immune system \[[@CR4]\], attention has shifted to alternative pharmacotherapies \[[@CR5], [@CR6]\]. Recent studies on *Zingiber officinale*, ginger, suggest that it might be as effective as some NSAIDs in the treatment of inflammation and related pain \[[@CR7], [@CR8]\].

In South Africa the use of plants to treat many diseases is widely practiced. According to Iwalewa et al. \[[@CR9]\], more than 115 plant species of 60 families are used in South Africa to treat pain-related inflammatory disorders in humans and animals. The bioactive principles in these plant species have been linked to secondary metabolites such as phenolic compounds (curcumins, flavonoids and tannins), saponins, terpenoids and alkaloids \[9, 10,\]. Biological and therapeutic properties attributed to these plant metabolites include antioxidant, anti-inflammatory, antimicrobial and anticancer activities \[[@CR10]\]. The mechanisms of action of many phenolic compounds such as flavonoids, tannins and curcumins are thought to be via their free radical scavenging activities or the inhibition of pro-inflammatory enzymes such as cyclo-oxygenases (COX) and lipoxygenases (LOX) in the inflammatory cascades \[[@CR11], [@CR12]\].

Flavonoids are a group of polyphenols thought to inhibit the biosynthesis of prostaglandins, end-products in the COX and LOX pathways of immunologic responses \[[@CR13]\]. There are three known isomeric-forms of COX i.e. COX-1 and COX-2, with a recently described third isomeric-form, COX-3 that is selectively inhibited by acetaminophen and related compounds \[[@CR14], [@CR15]\]. The selective inhibition of COX-2 is more desirable because the inhibition of COX-1 in the gastric mucosa is associated with the undesirable effects of NSAIDs \[[@CR16]\]. COX-2 is induced as an early response to pro-inflammatory mediators and stimuli such as endotoxins and cytokines \[[@CR17]\]. Upon induction, COX-2 synthesizes prostaglandins that contribute to inflammation, swelling and pain \[[@CR18]\]. Consequently, dual COX-2/LOX inhibitor compounds could potentially be developed into safer and more effective drugs for the treatment of inflammation since they could potentially inhibit biosynthesis of prostaglandins and leukotrienes respectively from arachidonic acid \[[@CR16], [@CR19]\], without the undesirable effects of NSAIDs.

Lipoxygenases are lipid-peroxidizing enzymes involved in the biosynthesis of leukotriene from arachidonic acid, mediators of inflammatory and allergic reactions. These enzymes catalyse the addition of molecular oxygen to unsaturated fatty acids such as linoleic and arachidonic acids \[[@CR20]\]. There are four main iso-enzymes already described, namely, 5-LOX, 8-LOX, 12-LOX and 15-LOX, depending on the site of oxidation in the unsaturated fatty acids \[[@CR20]\]. The common substrates for LOX are linoleic and arachidonic acids. For many in vitro studies, soy bean LOX is used due to difficulties in obtaining human LOX for bioassays \[[@CR21]\].

During inflammation, arachidonic acid is metabolized via the COX pathway to produce prostaglandins and thromboxane A~2~, or via the LOX pathway to produce hydroperoxy-eicosatetraenoic acids and leukotrienes \[[@CR22]\]. The LOX pathway is active in leucocytes and many immune-competent cells including mast cells, neutrophils, eosinophils, monocytes and basophils. Upon cell activation, arachidonic acid is cleaved from cell membrane phospholipids by phospholipase A~2~ and donated by LOX activating protein to LOX, which then metabolises arachidonic acids in a series of reactions to leukotrienes, a group of inflammatory mediators \[[@CR23]\]. Leukotrienes act as phagocyte chemo-attractant, recruiting cells of the innate immune system to sites of inflammation. For instance in an asthmatic attack, it is the production of leukotrienes by LOX that causes the constriction of bronchioles leading to bronchospasm \[[@CR8], [@CR16]\]. Therefore, the selective inhibition of LOX is an important therapeutic strategy for asthma \[[@CR8], [@CR16], [@CR24]\]. Inhibitors of the activities of LOX could provide potential therapies to manage many inflammatory and allergic responses. Medicinal plants may therefore be potential sources of inhibitors of COX-2/LOX that may have fewer side effects than NSAIDs \[[@CR24]\].

Nitric oxide (NO) is a short-lived free radical that mediates many biological processes. One of the functions of NO is to enhance the bactericidal and tumoricidal activities of activated macrophages \[[@CR25], [@CR26]\]. Excessive production of NO could however potentially lead to tissue damage and activation of pro-inflammatory mediators \[[@CR27], [@CR28]\]. The potential of extracts from medicinal plants to scavenge these free radicals and modulate inflammatory reactions has been demonstrated \[[@CR29]--[@CR31]\].

The objective of this study was to determine the anti-inflammatory activity of extracts in relevant bioassays in order to validate their use for pain relief and to identify plants that could be investigated in more detail.

Methods {#Sec2}
=======

Analytical grade chemicals were purchased from various suppliers in South Africa, and were used for the bioassays in the laboratory.

Preparation of plant materials {#Sec3}
------------------------------

Fresh leaves of the selected plants species were collected from the Manie van der Schijff Botanical Garden, University of Pretoria in March 2012. The plant materials were dried at room temperature in a well-ventilated room for a week. After drying, the materials were ground to fine powder using a MacSalab Model 200 grinder and stored in closed honey jars in the dark. Herbarium specimens for each of the plant species were prepared and deposited at HGWJ Schweickerdt Herbarium, University of Pretoria. Herbarium voucher specimen numbers (PRU voucher numbers) are provided in Table [1](#Tab1){ref-type="table"}.Table 1Percentage crude extract yield from the selected plant speciesPlant speciesFamily nameHerbarium specimen no.Common namesMedicinal usesYield (mg)Yield (%)*Acacia burkei*FabaceaePRU/120581/1/Adebayo SABlack monkey thornPainful back and eye \[[@CR10]\]1103.7*Acacia sieberiana*FabaceaePRU/120582/1/Adebayo SAPaperback thornFever, back aches and pain \[[@CR10]\]2107.0*Acokanthera oppositifolia*ApocynaceaePRU/120583/1/Adebayo SABushman's poisonHeadaches and pain \[[@CR56]\]52017.3*Bridelia micrantha*PhyllanthaceaePRU/120584/1/Adebayo SACoast gold leafAnti-inflammatory, abdominal pain \[[@CR57]\]34011.3*Clausena anisata*RutaceaePRU/120585/1/Adebayo SAMaggot-killerAbdominal pain, fever, rheumatism \[[@CR58]\]1906.3*Dichrostachys cinerea*FabaceaePRU/120586/1/Adebayo SASickle bushAnalgesic \[[@CR59], [@CR60]\]501.7*Ekebergia capensis*MeliaceaePRU/120587/1/Adebayo SACape ashHeadaches, backaches and cough \[[@CR58]\]1204.0*Erythrophleum lasianthum*FabaceaePRU/120588/1/Adebayo SAThornless treeHeadaches \[[@CR59]\]35011.6*Harpephyllum caffrum*AnacardiaceaePRU/120589/1/Adebayo SAWild plum or bush mangoPain alleviation \[[@CR60]\]1204.0*Kigelia africana*BignoniaceaePRU/120590/1/Adebayo SASausage treeAnalgesics, fever rheumatism \[[@CR61]\]602.0*Melianthus comosus*MelianthaceaePRU/120591/1/Adebayo SAHoney flowerRheumatism \[[@CR59]\]2608.7*Peltophorum africanum*FabaceaePRU/120592/1/Adebayo SAAfrican/weeping wattleChronic pains \[[@CR62]\]1003.3*Pittosporum viridiflorum*PittosporaceaePRU/120593/1/Adebayo SACheesewoodAbdominal pains \[[@CR58]\]1404.6*Plumbago auriculata*PlumbaginaceaePRU/120594/1/Adebayo SAPlumbagoHeadaches and malaria relief \[[@CR58]\]802.7*Polygala fruticosa*PolygalaceaePRU/120595/1/Adebayo SAButterfly bushVenereal diseases \[[@CR60]\]57019.0*Ptaeroxylon obliquum*PtaeroxylaceaePRU/120596/1/Adebayo SASneezewoodHeadaches \[[@CR60]\]2006.7*Rhus chirindensis*AnacardiaceaePRU/120597/1/Adebayo SARed currantArthritis, pain \[[@CR62]\]2006.7*Sclerocarya birrea*AnacardiaceaePRU/120598/1/Adebayo SAMarulaAnti-inflammatory, fever \[[@CR62]\]1505.0*Tecomaria capensis*BignoniaceaePRU/120599/1/Adebayo SACape honey suckleAbdominal pains \[[@CR59]\]1705.7*Terminalia phanerophlebia*CombretaceaePRU/120600/1/Adebayo SALebombo cluster leafAches, wounds and infections \[[@CR41], [@CR63]\]2107.0*Trichilia dregeana*MeliaceaePRU/120601/1/Adebayo SAThunder treeStomach ailment and backaches \[[@CR58]\]702.3*Terminalia prunioides*CombretaceaePRU/120602/1/Adebayo SALowveld cluster leafAbdominal pains, backaches \[[@CR41]\]1705.7*Tulbaghia violacea*AlliaceaePRU/120603/1/Adebayo SAWild garlicPain relief and fever \[[@CR64]\]66022.0*Warburgia salutaris*CanellaceaePRU/120604/1/Adebayo SAPepper-bark treeHeadaches, influenza and fever \[[@CR65]\]1505.0*Zanthoxylum capense*RutaceaePRU/120605/1/Adebayo SASmall knobwoodAbdominal pains \[[@CR65]\]2207.3

Preparation of crude extracts for biological assays {#Sec4}
---------------------------------------------------

Ground leaf powders (3 g) were extracted in 30 mL of 70 % acetone in clean honey jars and vigorously shaken for 3 h (Labotec model 20.2 shaker). The crude acetone extracts were filtered through Whatman No. 1 filter papers into pre-weighed honey jars, and then left open overnight for solvent evaporation. The honey jars were weighed again to determine the percentage yield of the crude extracts. For the biological assays, the crude extracts were reconstituted in dimethyl sulphoxide (DMSO) at a concentration of 10 mg/mL.

Determination of total phenolics and flavonoids {#Sec5}
-----------------------------------------------

Total phenolics were determined according to the method of Folin-Ciocalteu described by Makkar \[[@CR32]\], with slight amendments. In brief, 25 μL of crude extract was treated with 250 μL Folin-Ciocalteu reagent for 5 min. The reaction was stopped by adding 750 μL 20 % anhydrous sodium carbonate. The volume was made up to 5 mL with distilled water and incubated in the dark at room temperature for 2 h. After incubation, the absorbance was read at 760 nm with a spectrophotometer (HELIOS βT60, Separation Scientific). The phenolic content was determined from a standard curve of different concentrations of gallic acid DMSO. The results were expressed as mg/g gallic acid equivalent (GAE).

Flavonoid content of the extracts was determined using the methods of Yadav and Agarwala, \[[@CR33]\], also amended slightly. Crude extracts (100 μL) were dissolved in 300 μL methanol, to which 20 μL 10 % aluminium chloride was added. A further 20 μL of 1 M sodium acetate was added to the solution. The resultant solution was made up to 1 mL with distilled water. This was incubated at room temperature for 30 min in a microplate. After incubation, the absorbance was read at 450 nm in a microplate reader (SpectraMax 190, Molecular devices). Quercetin (10 mM) was used as a standard. The flavonoid content of each extract was expressed as mg/g quercetin equivalent (QE).

The 2, 2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay methods {#Sec6}
--------------------------------------------------------------------------

The DPPH radical-scavenging activity was determined using the method of Brand-Williams et al. \[[@CR34]\]. Ascorbic acid and Trolox were used as positive controls, methanol as negative control and extract without DPPH as blank. Results were expressed as percentage reduction of the initial DPPH absorption in relation to the control. The concentration of extract leading to 50 % reduction of DPPH (IC~50~) was also determined.

The 2, 2′-azinobis (3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) radical scavenging assay methods {#Sec7}
---------------------------------------------------------------------------------------------------

The ABTS radical scavenging capacity of the samples was measured with modifications of the 96-well microtitre plate method described by Re et al. \[[@CR35]\]. Trolox and ascorbic acid were used as positive controls, methanol as negative control and extract without ABTS as blank. The percentage of ABTS• + inhibition was calculated using the formula:$$\documentclass[12pt]{minimal}
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where OD represents the optical density or absorbance.

The IC~50~ values were calculated from the graph plotted as inhibition percentage against the concentration.

The ferric reducing ability of plasma (FRAP) assay methods {#Sec8}
----------------------------------------------------------

The FRAP assay was carried out according to the procedure of Benzie and Strain \[[@CR36]\] with slight modification. The FRAP assay depends upon the reduction of ferric tripyridyltriazine (Fe (III)-TPTZ) reduction to ferrous tripyridyltriazine (Fe (II)-TPTZ) by a reductant at low pH. Ferrous (II)-TPTZ has an intensive blue colour and can be monitored at 593 nm. Briefly, the FRAP reagent was prepared using an acetate buffer (pH 3.6), 10 mM TPTZ solution in 40 mM hydrochloric acid and 20 mM iron (III) chloride solution in proportions of 10:1:1 (v/v), respectively. Twenty five microliters of sample were added to 175 μL of the FRAP reagent. The absorbance of the reaction mixture was recorded at 593 nm (SpectraMax 190, Molecular devices) after 5 min. The standard curve was made using iron (II) sulphate solution (40--0.078 μg/mL), and the results were expressed as μg Fe (II)/g of extract. All the measurements were taken in triplicate and the mean values were calculated.

Inhibition of 15-lipoxygenase (15-LOX) enzyme {#Sec9}
---------------------------------------------

The 15-LOX (Sigma) was made up to a working solution of 200 units/mL and kept on ice. A volume of 12.5 μL of test sample or control (dissolved in DMSO) was added to 487.5 μL of 15-LOX in a 96-well microtitre plate and incubated at room temperature for 5 min. After incubation, 500 μL substrate solutions (10 μL linoleic acid dissolved in 30 μL ethanol, made up to 120 mL with 2 M borate buffer at pH 9.0) was added to the solution. After 5 min incubation at room temperature, the absorbance was measured with the microplate reader at 234 nm (SpectraMax 190, Molecular devices). Quercetin (1 mg/mL) was used as a positive control, while DMSO was used as the negative control (100 % enzyme activity or no enzyme inhibition). The percentage enzyme inhibition of each extract compared with negative control as 100 % enzyme activity was calculated using the equation;$$\documentclass[12pt]{minimal}
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The results were expressed as IC~50,~ i.e. concentration of the extracts and controls that resulted in 50 % 15-LOX inhibition plotted on a graph.

Inhibition of nitric oxide (NO) production {#Sec10}
------------------------------------------

### Cell culture {#Sec11}

The RAW 264.7 macrophage cell lines obtained from the American Type Culture Collection (Rockville, MD, USA) were cultured in plastic culture flasks in Dulbecco's Modified Eagle's Medium (DMEM) containing l-glutamine supplemented with 10 % foetal calf serum (FCS) and 1 % PSF (penicillin/streptomycin/fungizone) solution under 5 % CO~2~ at 37 °C, and were split twice a week. Cells were seeded in 96 well-microtitre plates and were activated by incubation in medium containing LPS (5 μg/mL) and various concentrations of extracts dissolved DMSO.

Measurement of nitrite {#Sec12}
----------------------

Nitric oxide released from macrophages was assessed by the determination of nitrite concentration in culture supernatant using the Griess reagent. After 24 h incubation, 100 μL of supernatant from each well of cell culture plates was transferred into 96-well microtitre plates and equal volume of Griess reagent was added. The absorbance of the resultant solutions in the wells of the microtitre plate was determined with a microtitre plate reader (SpectaMax 190 Molecular devices) after 10 min at 550 nm. The concentrations of nitrite were calculated from regression analysis using serial dilutions of sodium nitrite as a standard. Percentage inhibition was calculated based on the ability of extracts to inhibit nitric oxide formation by cells compared with the control (cells in media without extracts containing triggering agents and DMSO), which was considered as 0 % inhibition.

Cell viability {#Sec13}
--------------

To ensure that the observed nitric oxide inhibition was not due to cytotoxic effects, the cytotoxicity was also determined against Vero Monkey kidney cells as previously described by Mosmann \[[@CR37]\], with slight modifications. After removal of media, the cells were topped up with 200 μL DMEM. To each well, 30 μL of 15 mg/mL 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetra-zoliumbromide (MTT) was added. The cells were incubated at 37 °C with 5 % CO~2~. After 2 h, the medium was carefully discarded and the formed formazan salt was dissolved in DMSO. The absorbance was read at 570 nm (SpectraMax 190, Molecular devices). The percentage of cell viability was calculated with reference to the control (cells without extracts containing LPS taken as 100 % viability).

All the experiments to measure nitric oxide inhibition were conducted three times in triplicate.

Cytotoxicity assessments {#Sec14}
------------------------

The cytotoxicity of the extracts (dissolved in acetone) against Vero monkey kidney cells was assessed by the MTT reduction assay as previously described \[[@CR37]\] with slight modifications. Cells were seeded at a density of 1 × 10^5^ cells/mL (100 μL) in 96-well microtitre plates and incubated at 37 °C and 5 % CO~2~ in a humidified environment. After 24 h incubation, extracts (100 μL) at varying final concentrations were added to the wells containing cells. Doxorubicin (40--0.38 μM) was used as a reference compound. A suitable blank control with equivalent volume of acetone was also included and the plates were further incubated at 37 °C for 48 h in a CO~2~ incubator. The medium was removed by aspiration and cells were then washed twice with PBS, followed by suspension in fresh medium (200 μL). Then, 30 μL of MTT (5 mg/mL in PBS) was added to each well and the plates were incubated at 37 °C for 4 h. The medium was removed by aspiration and 100 % DMSO (100 μL) added to dissolve the formed formazan crystals. The absorbance was measured on SpectraMax 190 (Molecular devices) microtitre plate reader at 570 nm. The percentage of cell growth inhibition was calculated based on a comparison with untreated cell. The selectivity index (SI) values were calculated by dividing cytotoxicity LC~50~ values by the MIC values (SI = LC~50~/MIC).

Statistical analysis {#Sec15}
--------------------

All results are presented as the means of triplicate experiments. Differences between test extracts in these experiments was assessed for significance using analysis of variance (ANOVA) and student *t*-test, where probability (p ≤ 0.05) was considered significant.

Results and discussion {#Sec16}
======================

The results obtained in this study are presented below using Tables and Figures for ease of interpretation and data comparison.

Crude yield of extracts {#Sec17}
-----------------------

*Tulbaghia violacea* yielded 22 % of crude acetone extract from 3 g plant material, the highest yield of all the plant species in this study. This plant grows as a bulbous rhizome, which had to be cut into pieces for proper drying. The presence of reserve materials might account for the high yield of extract from the plant unlike the other plant species in the study, whose leaves could be easily dried when left open in the drying room for three days (Table [1](#Tab1){ref-type="table"}).

Total phenolics and flavonoid contents {#Sec18}
--------------------------------------

The high extract yield from *T. violacea* did not correlate well with its total phenolics and flavonoid content. This may be due to high concentrations of carbohydrates as reserve material in the rhizome. *Terminalia phanerophlebia* and *Terminalia prunioides* with lower crude extract yield of 7 % and 5.7 % respectively contained more total phenolics than *T. violacea* (Table [1](#Tab1){ref-type="table"}). The highest amounts of total phenolic compounds were obtained from *T. phanerophlebia* (86 mg/g GAE) followed by *T. prunioides* (79 mg/g GAE) and *M. comosus* (64.7 mg/g GAE).

In terms of flavonoid content, the three highest yields were obtained from *D. cinerea* (0.54 mg/g QE), *T. phanerophlebia* (0.53 mg/g QE) and *S. birrea* (0.52 mg/g QE), respectively (Fig. [1](#Fig1){ref-type="fig"}). The overall results suggest that generally, there was poor correlation between total phenolics and flavonoid contents in the selected plant species (R^2^ = 0.05); however, *T. phanerophlebia* seems to be an exception. Not much study has been done on phyto-chemical screening of the leaves of *T. phanerophlebia,* but available literature data indicates the presence of triterpenoids and tannins \[[@CR10]\]. The dried leaves of the plant are generally used as decoction in water to treat rheumatism, stomach pains and diarrhoea \[[@CR38]\]. The high content of total phenolics and flavonoids, possibly tannins, triterpenoids and other secondary metabolites may be responsible for its therapeutic uses.Fig. 1Relationship between total phenolic and flavonoid contents. Results indicated that there was no correlation between the total phenolic content and flavonoid content of the extracts tested (R^2^ = 0.05)

Data from literature sources on the secondary metabolites present in the leaves of *T. prunioides* is scarce. Its antibacterial \[[@CR39]\], Thin Layer Chromatography profile and antifungal activity \[[@CR40]\], and antioxidant activity \[[@CR41]\] has been reported. However, the dried leaves are used as decoction traditionally for the relief of stomach pains. Our study indicated that it contained relatively high amounts of phenolic compounds, possibly flavonoids, tannins and terpenoids, this may be responsible for the antimicrobial and antioxidant activity. The third plant species with a high phenolic content among the selected plants was *M. comosus.* Potential anti-fungal and lipoxygenase inhibitory properties of this plant species have already been reported. This may be associated with its flavonoid and cardiac glycoside content \[[@CR42]\]. Phenolic compounds, especially flavonoids are well known for their anti-oxidant activitiy and lipoxygenase enzyme inhibitory activity \[[@CR43]\].

Anti-inflammatory activities {#Sec19}
----------------------------

The main objective of the study was to evaluate the anti-inflammatory activity of the selected extracts using the anti-15 LOX model of inhibition. Therefore the three plants extracts with promising inhibitory activity of 15-LOX were selected for further investigation. As illustrated in Fig. [2](#Fig2){ref-type="fig"}, crude extracts harvested from two of the plant species tested, *P. africanum* (IC~50~ = 12.42 μg/mL) and *Z. capense* (IC~50~ = 14.92 μg/mL), had promising 15-LOX inhibitory activities compared with quercetin (IC~50~ = 8.75 μg/mL) used as a positive control. These complex crude extracts may contain compounds with higher activity than quercetin. These results suggest that the bioactive constituent(s) of *P. africanum* had both antioxidant and anti-inflammatory activities. Antioxidants act by scavenging free radicals such as reactive oxygen species, hydroxyl radicals and nitric oxide while anti-inflammatory mediators act by modulating the activities of pro-inflammatory enzymes and cytokines.Fig. 2Inhibitory activities of crude plant extracts on 15-LOX. The extract with the highest inhibitory activity on 15-LOX was obtained from *P. africanum* (IC~50~ = 12.42 μg/mL) compared with quercetin controls (IC~50~ = 8.75 μg/mL)

The lipoxygenase group of enzymes (5, 8, 12 and 15-LOX) plays a role in many inflammatory disorders. The isomeric enzyme, 15-LOX is an important enzyme involved in the synthesis of leukotrienes from arachidonic acids. Biologically active leukotrienes are mediators of many pro-inflammatory and allergic reactions, therefore the inhibition of the synthesis of leukotrienes by 15-LOX is considered as one of the therapeutic strategies in the management of inflammatory conditions \[[@CR17], [@CR24]\]. Assessment of extracts derived from more than 180 different plant species indicated their potential dual COX/LOX inhibitory capacity \[[@CR24]\]. Extracts or compounds from plants inhibiting the pro-inflammatory activities of these enzymes may contain potential leads or templates for the development of potent anti-inflammatory drugs \[[@CR44]\]. Further work is required to properly characterize the compound(s) responsible for the anti-inflammatory principles in these plant species, and also understand their mechanisms of action. The three plants extracts with promising inhibitory activity on 15-LOX were selected for further investigation.

Inhibition of nitric oxide (NO) production by the three extracts with promising 15-LOX inhibitory activity {#Sec20}
----------------------------------------------------------------------------------------------------------

The inhibitory activity of the extracts on NO production by induced RAW 264.7 macrophage cell lines is presented in Table [2](#Tab2){ref-type="table"}. *Clausena anisata* crude acetone extracts had the best inhibitory activity on NO production (96.9 % inhibition/ 71.3 % cell viability) at 6.25 μg/mL compared with *P. africanum* (91.3 %/ 65.7 %), *Z. capense* (62.2 %/ 82.5 %) and quercetin (91.1 %/ 73.8 %) respectively (Table [2](#Tab2){ref-type="table"}). Extracts with good inhibitory activity on NO production and a low cytotoxicity are more useful. Release of NO promotes inflammation, therefore extracts that could act as scavengers of NO, or inhibitors of its production, especially with corresponding low cytoxicity could be used to mitigate the propagation of inflammation by NO. The inhibition of NO production by extracts derived from medicinal plants may be due to the inhibition of inducible nitric oxide synthase activity and/or its expression \[[@CR30], [@CR31]\].Table 2Inhibitory activities of *Peltophorum africanum (PA),* *Clausena anisata (CA) and* *Zanthoxylum capense* (ZC) on the LPS-activated NO production in RAW 264.7 macrophagesSamplesConcentration (μg/mL)NO (μM)% NO inhibition% Cell viability*Peltophorum africanum*250.60 ± 0.0292.3266.6412.50.39 ± 0.1494.9279.716.250.67 ± 0.4291.3365.713.121.97 ± 0.2474.6260.93*Clausena anisata*250.94 ± 0.0787.863.4312.50.38 ± 0.2595.1763.316.250.24 ± 0.1496.9071.293.120.55 ± 0.0892.9480.31*Zanthoxylum capense*251.06 ± 0.5886.3872.7912.51.31 ± 0.5183.1690.146.252.94 ± 0.4662.2382.453.125.22 ± 0.6732.8879.24Quercetin250.35 ± 0.1095.5449.3312.50.30 ± 0.0896.1660.696.250.69 ± 0.0591.0873.763.122.50 ± 0.4867.9373.10Values are expressed as mean ± SD

Antioxidant activities {#Sec21}
----------------------

Phytochemical evaluation of extracts derived from *P. africanum* has yielded bergenin \[[@CR45]\] and betulinic acid \[[@CR46]\]. Secondary metabolites are stored in various parts of the plant; however coumarins constitute the major compounds in the leaves \[[@CR47]\]. The plant is widely used traditionally for treating wounds, back and joint pains and dysentery, among others \[[@CR48]\], but reported biological activities of the extracts are limited to antimicrobial activity \[[@CR49]\]. The bioactive compounds responsible for the observed effects have not been properly characterized and the mechanism of activity has not been explored. In the case of *Z. capense,* biological activities such as anti-mycobacterial \[[@CR50]\] and anti-proliferative effects \[[@CR51]\] have been reported, subsequent to a bio-assay guided isolation of six alkaloids from the roots of the plant \[[@CR52]\].

Extracts of *P. africanum* had the best antioxidant activity among the three extracts that were tested (Table [3](#Tab3){ref-type="table"}). With IC~50~ of 4.67 ± 0.31 and 7.71 ± 0.36 μg/mL using the DPPH and ABTS assays respectively, the results were comparable to that of Trolox positive controls (2.74 ± 0.08 and 7.21 ± 0.42 μg/mL). This is consistent with the findings of Bizimenyera, 2007 \[[@CR53]\]. An extensive review of extracts of African medicinal plants with potent anti-oxidant activities by Atawodi \[[@CR54]\] indicated that the mechanism(s) of action extracts was by free radical scavenging. In addition, the synergistic effects of natural products also enhance their antioxidant activities \[[@CR53]\]. These results suggest that the bioactive constituent(s) of *P. africanum* had both antioxidant and anti-inflammatory activities. Antioxidants acts by scavenging free radicals such as reactive oxygen species, hydroxyl radicals and nitric oxide while anti-inflammatory mediators act by modulating the activities of pro-inflammatory enzymes and cytokines. Accumulation of free radicals result in cellular injury, and may be the cause of many diseases.Table 3Cytotoxicity, antioxidant activity, total phenolics and total flavonoids content of acetone extracts of *Clausena anisata, Peltophorum africannum and Zanthoxylum capense*SamplesVERO IC~50~ (μg/mL)DPPH IC~50~ (μg/mL)ABTS IC~50~ (μg/mL)FRAP IC~50~ (μgFe (II)/g)TPC (mg GAE/g)TFC (mg QE/g)*Clausena anisata*23.19 ± 0.58119.36 ± 3.7864.08 ± 2.61146.52 ± 11.97109.63 ± 7.62159.01 ± 1.88*Peltophorum africanum*103.45 ± 0.414.67 ± 0.317.71 ± 0.36434.54 ± 29.82255.26 ± 28.6980.00 ± 8.06*Zanthoxylum capense*\>1000138.78 ± 13.24132.10 ± 8.1093.96 ± 7.68372.27 ± 16.0638.59 ± 6.65Trolox2.74 ± 0.087.21 ± 0.42NdNdNdAscorbic. Acid2.92 ± 0.1413.57 ± 0.44NdNdNdValues are expressed as mean ± SDNd: not determined

Cytotoxicity {#Sec22}
------------

Our results indicated that extracts of *Z. capense* had the lowest cytotoxicity on Vero Monkey kidney cell lines (Table [3](#Tab3){ref-type="table"}) among those tested (IC~50~ \> 1000 μg/mL). *Peltophorum africanum* extracts also had a relatively low toxicity of with an IC~50~ of 103 μg/mL that was comparable to values in an earlier report \[[@CR53]\]. The safety of herbal remedies remains a concern because few reports exist on the safe use of these products. Many extracts have been shown to contain potentially harmful substances that could impact adversely on human health when consumed \[[@CR55]\]. Although, our study suggests that extracts of *Z. capense* had low toxicity on Vero cell lines (≥1000 μg/mL) (Table [3](#Tab3){ref-type="table"}), this observation has not yet been confirmed using in animal studies.

Conclusions {#Sec23}
===========

Our results provide further scientific evidence supporting the use of *P. africanum, Z. capense* and *C. anisata* as anti-inflammatory and pain relief remedies in traditional medicine. To be used as herbal products the safety in animal experiments have to be confirmed. The good inhibitory activity of crude extracts containing many other compounds on 15-LOX inhibition in these plant species means that it probably contains compounds with excellent activities. Further work is required to isolate, identify and characterize the bioactive compounds that are responsible for the activities. Once the active compounds have been isolated the mechanism of activity can be examined.
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